DES MOINES, Iowa (KCRG) - Iowans will get a chunk of a $4.9 million multi-state settlement from a lab overcharging for COVID tests, Attorney General Brenna Bird announced Wednesday. GS Labs was ...

Nearly $1 million in restitution is being repaid to Washingtonians following a multistate settlement with a COVID-19 testing lab that overcharged its patients and failed to deliver timely results. An ...

GS Labs, the drive-in COVID testing firm accused of unfairly charging sky-high prices at the height of the pandemic, is paying $4.87 million to settle allegations the company overcharged patients and ...

A PCR diagnostic developed by Roche for the Bundibugyo form of Ebola is being offered to health systems at the front lines of the current outbreak in central Africa. The diagnostics giant said it ...

Temperatures could reach 90 degrees in some areas of western Washington as a heatwave continues through Wednesday. by KOMO News Staff SEATTLE — Washington residents who paid for COVID-19 tests through ...

Roche Holding AG has rapidly developed a research-use only molecular PCR test to detect the rare Ebola Bundibugyo virus, to support response efforts amid the ongoing outbreak in the Democratic ...

Roche Holding struck a deal with Nurix Therapeutics NRIX0.53%increase; up pointing triangle to license an experimental blood-cancer drug for up to $2.3 billion, expanding its pipeline in oncology and ...

Roche said that it "will need to carefully assess future investment opportunities in Germany in light of the evolving policy framework.” (Sheldon Cooper/SOPA Images/LightRocket/Getty Images) As news ...

A glimmer of hope in Roche's failed persevERA trial has given the Swiss pharma confidence in launching a new phase 3 study of its giredestrant in combination with CDK4/6 inhibitor in early breast ...

ZURICH, June 8 (Reuters) - Swiss pharmaceutical giant Roche (ROPC.S), opens new tab has entered an exclusive licensing and collaboration ‌agreement with Nurix Therapeutics (NRIX.O), opens new tab ...

FRANKFURT, June 9 (Reuters) - The Swiss pharmaceutical and diagnostics giant Roche (ROPC.S), opens new tab said it is sticking to its planned investments in Germany, unlike some of ‌its competitors ...